• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Keranova raises $26.5 million for ophthalmic surgical robot

Keranova raises $26.5 million for ophthalmic surgical robot

September 10, 2019 By Nancy Crotti

Ophthalmic surgery device maker Keranova said today that it has raised $26.5 million (€24 million)  in a second round of financing,.

Long-standing shareholders Mérieux Equity Partners and Supernova Invest led the round, joined by Financière Arbevel, Tourrette Investissement and other international investors.

Saint-Etienne, France-based Keranova said it will use the money to fund the development of its technologies and to obtain the regulatory authorizations needed to market its robot-assisted laser designed for cataract surgery. The company said it may also pursue other applications for the device, such as myopia and astigmatism.

Keranova claims its device is the first robot-assisted laser in the world able to perform photoemulsification of cataractous lenses. The technique was designed to replace traditional phacoemulsification using manual equipment, and cannot be used with other laser devices that are fitted with older technology, the company said.

Keranova was founded in 2016 and raised  $4.4 million (€4 million) during a first round of financing, to which Bpifrance added $1.1 million (€1 million).

“We are extremely proud to have succeeded in producing such a revolutionary machine in such a short amount of time and are very pleased to have attracted new financial partners,” said Keranova founder Fabrice Romano in a news release. “We are very grateful to them and are eager to promote this innovative surgical equipment as the new gold standard in anterior eye segment surgery.”

“Less than four years after our first round of financing, Keranova’s development team has produced a new cataract surgery device, while adhering to the initial scope of its work,” added Valérie Calenda, partner at Mérieux Equity Partners and a member of Keranova’s board of directors. “The first-in-human surgical procedures have been very encouraging. As a benchmark shareholder, we support Keranova in marketing a revolutionary device with the ability to transform the way in which cataract surgery is performed on millions of people worldwide.”

Keranova said it is organizing a symposium where it will unveil its surgical robot to an audience of specialists during the European Society of Cataract and Refractive Surgeons convention, September 14–18 in Paris.

Filed Under: Business/Financial News, Featured, Funding Roundup, News Well, Optical/Ophthalmic, Surgical, Surgical Robotics Tagged With: Keranova

More recent news

  • Sequel Med Tech’s automated twiist pump scores FDA clearance in type 2 diabetes
  • FDA posts alert for Edwards Lifesciences mitral valve delivery system after patient death
  • Former Medtronic RDN leader joins Teleflex
  • CMR Surgical CEO outlines the path forward for Stryker’s robotics partnership
  • Stryker earns FDA clearance for new bone and soft tissue removal platform

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy